CDH
MRNA icon

Charles D. Hyman’s Moderna MRNA Stock Holding History

Charles D. Hyman’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,475
Closed -$227K – 244
2023
Q1 		$227K Hold
1,475
– – 0.02% 227
2022
Q4 		$265K Buy
+1,475
New +$241K 0.02% 204
2022
Q3 		– Sell
-1,475
Closed -$211K – 238
2022
Q2 		$211K Buy
+1,475
New +$211K 0.02% 229
2021
Q4 		– Sell
-535
Closed -$206K – 239
2021
Q3 		$206K Buy
+535
New +$197K 0.01% 228

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles D. Hyman's MRNA Position: Q2 2023 in Review

Charles D. Hyman sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,475 shares — an estimated $227K sold.

Charles D. Hyman first reported a position in MRNA in Q3 2021 and held it in 4 quarters. The position peaked at $265K in Q4 2022. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Charles D. Hyman reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Charles D. Hyman sold 1,475 Moderna shares in Q2 2023, an estimated $227K.
  • Charles D. Hyman first reported a position in Moderna in Q3 2021 and held it in 4 quarters.
  • Charles D. Hyman's Moderna position peaked at $265K in Q4 2022.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Charles D. Hyman's 13F filing for Q2 2023, filed 8 Aug 2023.